share_log

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Lowers Price Target to $8

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Lowers Price Target to $8

Alliance Global Partners维持对Tonix Pharmicals的买入,将
Benzinga ·  2023/08/01 12:17

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and lowers the price target from $18 to $8.

Alliance Global Partners分析师詹姆斯·莫洛伊维持Tonix Pharmicals(纳斯达克股票代码:TNXP)的买入,并将目标股价从18美元下调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发